中東とアフリカの外傷性脳損傷治療市場の規模、トレンド、成長レポート2032

中東・アフリカの外傷性脳損傷治療市場規模、シェア、トレンド分析レポート

Market Size in USD Billion

CAGR : 4.40 %

USD 202.80 Million USD 144.04 Million 2024 2032

予測期間	2025 –2032
市場規模（基準年）	USD 202.80 Million
Market Size (Forecast Year)	USD 144.04 Million
CAGR	4.40 %
主要市場プレーヤー	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock

中東およびアフリカの外傷性脳損傷治療市場のセグメンテーション、治療（手術、緊急救急治療、投薬）、投与経路（非経口、経口、その他）、患者の年齢（子供、ティーンエイジャー、高齢者）、性別（男性、女性）、傷害原因（転倒、自動車事故、スポーツ、その他）、エンドユーザー（病院、神経科クリニック、独立系薬局、その他） - 2032年までの業界動向と予測

外傷性脳損傷治療市場規模

中東およびアフリカの外傷性脳損傷治療市場は、2024年に2億280万米ドルと評価され、 2032年までに1億4404万米ドルに達すると予想されています。
2025年から2032年の予測期間中、市場は主に外傷性脳損傷（TBI）の発生率の増加に牽引され、4.4％のCAGRで成長すると予想されます。
この成長は、外傷性脳損傷（TBI）の発生率の増加、TBI治療における低侵襲手術の採用の増加などの要因によって推進されており、外傷性脳損傷治療の需要を促進しています。

外傷性脳損傷治療市場分析

外傷性脳損傷（TBI）治療市場は、TBIに対する認識の高まり、診断技術の進歩、事故やスポーツ関連の傷害の発生率の増加により、効果的な治療オプションとリハビリテーション療法の需要の高まりにより、大幅に拡大すると予測されています。
市場では、神経保護剤、幹細胞療法、高度なリハビリテーション技術など、革新的な治療法が急増しており、TBI患者の回復成果を向上させ、治療の展望を広げています。
北米地域は、高度な医療インフラ、多大な研究投資、そしてTBIの高い罹患率によって、外傷性脳損傷治療市場の主要な地域の一つとして際立っています。

レポートの範囲と外傷性脳損傷治療市場のセグメンテーション

属性	外傷性脳損傷治療市場の洞察
対象セグメント	治療別：手術、緊急治療、薬物療法投与経路：非経口、経口、その他患者の年齢別：小児、ティーンエイジャー、高齢者性別：男性と女性傷害の原因別：転倒、交通事故、スポーツ、その他エンドユーザー別:病院、神経科クリニック、独立系薬局など
対象国	中東およびアフリカサウジアラビア南アフリカエジプトアラブ首長国連邦イスラエルクウェートその他の中東およびアフリカ
主要な市場プレーヤー	ファイザー社（米国）テバ・ファーマシューティカルズUS社（米国） Fresenius SE & Co. KGaA（Fresenius Kabi AG）（ドイツ）ビアトリス社（米国）アムニール・ファーマシューティカルズLLC（米国）ドクター・レディーズ・ラボラトリーズ社（インド）サン・ファーマシューティカル・インダストリーズ（インド）ルパン（インド）ヒクマ（ヨルダン）オーロビンドファーマUS（インド） ICUメディカル（米国） B.ブラウンメディカル社（ドイツ）アレンビック・ファーマシューティカルズ・リミテッド（インド）メルツ・セラピューティクス（ドイツ）アドバケア（南アフリカ）マクジマー（インド）ジェダックス・ペアレントラル・プライベート・リミテッド（インド）セージェント・ファーマシューティカルズ社（米国）スイスファーマナイジェリアリミテッド（ナイジェリア）
市場機会	外傷性脳損傷（TBI）における個別化・標的治療の増加外傷性脳損傷（TBI）治療における脳刺激技術の発展外傷性脳損傷（TBI）の診断における人工知能（AI）の応用の増加
付加価値データ情報セット	データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力の概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品の概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。

外傷性脳損傷治療市場の動向

「TBI治療における遠隔医療の導入拡大」

遠隔医療により、患者は遠隔診察やリハビリテーションサービスを受けることができ、地方や医療サービスが行き届いていない地域の人々が専門的なケアを受けられるようになり、TBI患者へのタイムリーな介入が容易になります。
遠隔医療を利用することで、交通費や生産性の低下など、対面診療に伴うコストが削減され、患者と医療提供者の両方にとって経済的に実行可能な選択肢となります。

2021年3月、NCBIは、後天性脳損傷患者とその介護者に対する遠隔医療訪問は、移動の負担を軽減し、コンプライアンスを向上させ、全体的な満足度を高めることができると発表しました。遠隔医療の環境において、管理戦略はほとんど影響を受けず、遠隔リハビリテーションの選択肢は、多くの関連する障害の治療において、対面療法と同等かそれ以上の効果があることが分かっています。

遠隔医療プラットフォームは継続的なモニタリングとフォローアップケアを可能にし、医療専門家が患者の病状の遠隔追跡、リアルタイムフィードバックの提供、必要に応じて治療計画の調整を可能にし、最終的にはTBI管理における患者の転帰を向上させます。

外傷性脳損傷治療市場の動向

ドライバ

「外傷性脳損傷（TBI）の発生率の増加」

As the number of cases continues to rise due to various contributing factors such as road accidents, sports-related injuries, and falls, particularly among the elderly population. Road traffic accidents remain one of the leading causes of TBI worldwide, with the growing number of vehicles on the road, reckless driving behaviours
Sports-related injuries, particularly in contact sports like football, boxing, and rugby, have further fueled the surge in TBI cases, with increasing awareness of concussion-related complications prompting the need for advanced treatment solutions

For instance,

In March 2025, as per the article published by ScienceDirect, there were 20.84 million incident cases and 37.93 million prevalent cases of Traumatic Brain Injury (TBI) Middle East and Africaly, leading to 5.48 million, Years Lived With Disability (YLDs). The rising burden of TBI increases the demand for advanced treatments, driving investments in diagnostics, neurosurgery, and rehabilitation, ultimately fueling the growth of the Middle East and Africa TBI treatment market
In October 2024, according to the data published by Centers for Disease Control and Prevention, In 2021, there were 69,473 TBI-related deaths, and in 2020, approximately 214,110 hospitalizations occurred. This equates to over 586 hospitalizations and 190 deaths per day, with individuals aged 75+ and males being the most affected. The rising burden of TBI necessitates advanced treatment solutions, driving growth in the Middle East and Africa TBI treatment market

Factors such as road accidents, sports injuries, and falls—especially among the elderly—contribute to increase in TBI. Growing awareness and demand for advanced treatments, including neurosurgery, drug therapies, and rehabilitation, are fuelling market expansion and technological advancements in TBI management

Opportunity

“Rising Personalized and Targeted Therapies in Traumatic Brain Injury (TBI)”

TBI is a highly variable condition influenced by severity, location, and patient-specific factors, making traditional treatments less effective. Advances in biomarker discovery, neuroimaging, and computational modeling help identify distinct injury patterns, enabling more targeted therapies. Pharmacogenomics enhances drug selection and dosing, minimizing side effects while maximizing effectiveness. Personalized rehabilitation strategies, tailored to cognitive and motor impairments, further optimize recovery by aligning treatments with individual healing trajectories

For instance,

In February 2022, as per NCBI, researchers have discovered genetic risk factors like APOE4 and BDNF Val66Met polymorphisms that impact TBI recovery. By focusing on these variations, personalized treatments can lower harmful biomarkers, enhance neuroprotection, and improve rehabilitation. This approach tailors’ therapies to individual needs, ultimately leading to better long-term functional outcomes for TBI patients
In February 2024, article by MDPI TBI presents a significant opportunity to enhance patient outcomes. Advancements in biomarker discovery, pharmacogenomics, and neuroimaging enable precision treatments tailored to individual injury profiles. Emerging therapies, including neurostimulation and stem cell treatments, further expand possibilities for effective, patient-specific interventions in TBI management

Personalized and targeted therapies present a transformative approach to managing Traumatic Brain Injury (TBI) by tailoring interventions to individual genetic and molecular profiles. These strategies focus on specific biomarkers and cellular processes to reduce secondary damage and improve recovery. By optimizing treatment, personalized therapies enhance outcomes and promote long-term functional recovery for TBI patients.

Restraint/Challenge

“Difficulties in Overcoming the Blood-Brain Barrier for TBI Treatment”

A significant challenge in Traumatic Brain Injury (TBI) treatment is the disruption of the Blood-Brain Barrier (BBB). After a TBI, the Blood-Brain Barrier (BBB )often becomes compromised, allowing harmful substances to enter the brain, which can worsen injury and hinder recovery. This creates difficulty in delivering therapeutic agents effectively, limiting the success of many treatments designed to aid recovery and protect brain tissue.
Furthermore, restoring the integrity of the Blood-Brain Barrier (BBB) without causing additional harm remains a major challenge. Developing targeted delivery systems that can bypass the damaged barrier without introducing further risks is crucial for improving TBI treatment outcomes.

For instance,

In January 2022, Springer Nature Publishing Inc reported that Blood-Brain Barrier (BBB) it restricts the delivery of therapeutic agents to the brain. Even when the BBB is compromised after injury, many drugs, particularly large molecules, still struggle to penetrate it, limiting the effectiveness of treatments and complicating targeted therapies.
In June 2024, nature reviews neurology reported that BBB dysfunction can persist from days to years after TBI, contributing to long-term neurological complications. This dysfunction is linked to oedema, neuroinflammation, and alterations in neuronal networks, complicating treatment strategies and leading to cognitive impairments, depression, and post-traumatic epilepsy, thus challenging effective recovery and therapeutic approaches

血液脳関門（BBB）の破綻は、外傷性脳損傷（TBI）の治療において大きな課題となります。治療の効果的な実施を阻害し、脳損傷を悪化させるからです。BBBの機能不全が持続すると、炎症、脳腫脹、認知障害などの長期的な合併症を引き起こす可能性があります。活性酸素消去療法などのアプローチは脳機能の改善に有望ですが、BBB損傷の変動性は治療戦略を複雑化させます。TBIの転帰を改善するには、革新的な薬物送達システムと、BBBの健全性をモニタリングし、より効果的な治療を可能にし、長期的な神経障害を軽減するためのより優れた方法が不可欠です。

外傷性脳損傷治療市場の展望

市場は、治療、患者の年齢、性別、傷害の原因、およびエンドユーザーに基づいてセグメント化されています。

セグメンテーション	サブセグメンテーション
治療別	処理手術緊急医療医薬品
患者の年齢別	患者の年齢子供たちティーンエイジャー長老
性別別	性別男女性
傷害の原因別	傷害の原因滝自動車交通スポーツその他
エンドユーザー別	エンドユーザー病院神経科クリニック独立系薬局その他

外傷性脳損傷治療市場の国別分析

「南アフリカは外傷性脳損傷治療市場において支配的な国です」

南アフリカは、交通事故の増加と医療インフラの改善により、外傷性脳損傷市場をリードすると予想されています。政府の取り組みや啓発プログラムの強化も、市場の成長を後押ししています。

「南アフリカは最も高い成長率を記録すると予測されている」

南アフリカの外傷性脳損傷（TBI）評価および管理デバイス市場は、医療技術の進歩とTBI治療の認知度の高まりにより、約2000万米ドルの複合年間成長率（CAGR）で成長すると予測されています。

外傷性脳損傷治療の市場シェア

市場競争環境は、競合他社ごとに詳細な情報を提供します。企業概要、財務状況、収益、市場ポテンシャル、研究開発投資、新規市場への取り組み、中東およびアフリカにおけるプレゼンス、生産拠点・設備、生産能力、強みと弱み、製品投入、製品群の幅広さ、アプリケーションにおける優位性などの詳細が含まれます。上記のデータは、各社の市場への注力分野にのみ関連しています。

市場で活動している主要なマーケットリーダーは次のとおりです。

ファイザー社（米国）
テバ・ファーマシューティカルズUS社（米国）
Fresenius SE & Co. KGaA（Fresenius Kabi AG）（ドイツ）
ビアトリス社（米国）
アムニール・ファーマシューティカルズLLC（米国）
ドクター・レディーズ・ラボラトリーズ社（インド）
サン・ファーマシューティカル・インダストリーズ（インド）
ルパン（インド）
ヒクマ（ヨルダン）
オーロビンドファーマUS（インド）
ICUメディカル（米国）
B.ブラウンメディカル社（ドイツ）
アレンビック・ファーマシューティカルズ・リミテッド（インド）
メルツ・セラピューティクス（ドイツ）
アドバケア（南アフリカ）
マクジマー（インド）
ジェダックス・ペアレントラル・プライベート・リミテッド（インド）
セージェント・ファーマシューティカルズ社（米国）
スイスファーマナイジェリアリミテッド（ナイジェリア）

外傷性脳損傷治療市場の最新動向

フレゼニウス・カビは2021年2月、オーストリアの施設を拡張し、医薬品および医療技術における生産能力とイノベーションを強化しました。この拡張により、製造効率が向上し、救命医療製品の安定供給が確保され、研究の進展が促進されます。生産能力とオペレーションの卓越性を高めることで、フレゼニウス・カビは市場でのプレゼンスを強化し、中東およびアフリカにおける医療ソリューションへの需要の高まりに対応します。
2024年2月、Viatris社とIdorsia社は、複数の治療領域における革新的な治療法の開発を目指し、中東およびアフリカにおける大規模な研究開発提携を締結しました。この提携は、Idorsia社の創薬専門知識とViatris社の中東およびアフリカにおけるネットワークを活用し、画期的な治療法の開発を加速するとともに、両社のパイプラインを拡大することで、世界中の未充足の医療ニーズへの取り組みを強化します。

SKU-73835

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

画像をクリックすると拡大します

インタラクティブなデータ分析ダッシュボード
成長の可能性が高い機会のための企業分析ダッシュボード
カスタマイズとクエリのためのリサーチアナリストアクセス
インタラクティブなダッシュボードによる競合分析
最新ニュース、更新情報、トレンド分析
包括的な競合追跡のためのベンチマーク分析のパワーを活用

デモのリクエスト

表のリスト

TABLE 1 NON-INVASIVE THERAPEUTIC APPROACHES’ EFFICIENCY IN DIFFERENT PHASES OF TBI

TABLE 2 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 3 MIDDLE EAST AND AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 4 MIDDLE EAST AND AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 5 MIDDLE EAST AND AFRICA IMMEDIATE EMERGENCY CARE IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 6 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 7 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 8 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 9 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 10 MIDDLE EAST AND AFRICA CHILDREN IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 11 MIDDLE EAST AND AFRICA TEENAGER IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 12 MIDDLE EAST AND AFRICA ELDER IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 13 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 14 MIDDLE EAST AND AFRICA MALE IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 15 MIDDLE EAST AND AFRICA FEMALE IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 16 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 17 MIDDLE EAST AND AFRICA FALLS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 18 MIDDLE EAST AND AFRICA MOTOR VEHICLE TRAFFIC IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 19 MIDDLE EAST AND AFRICA SPORTS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 20 MIDDLE EAST AND AFRICA OTHERS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 21 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 22 MIDDLE EAST AND AFRICA HOSPITALS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 23 MIDDLE EAST AND AFRICA NEUROLOGY CLINICS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 24 MIDDLE EAST AND AFRICA INDEPENDENT PHARMACIES IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 26 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 27 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 28 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 29 NORTH AMERICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 30 NORTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 31 NORTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 32 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 33 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 34 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 35 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 36 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 37 U.S. SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 38 U.S. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 39 U.S. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 40 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 41 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 42 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 43 U.S. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 44 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 45 CANADA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 46 CANADA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 47 CANADA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 48 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 49 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 50 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 51 CANADA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 52 MEXICO TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 53 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 54 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 55 EUROPE SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 56 EUROPE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 EUROPE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 58 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 59 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 60 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 61 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 62 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 63 GERMANY SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 64 GERMANY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 65 GERMANY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 66 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 67 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 68 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 69 GERMANY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 70 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 71 U.K. SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 72 U.K. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 73 U.K. MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 74 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 75 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 76 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 77 U.K. TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 78 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 79 FRANCE SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 80 FRANCE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 FRANCE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 82 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 83 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 84 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 85 FRANCE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 86 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 87 ITALY SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 88 ITALY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 ITALY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 90 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 91 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 92 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 93 ITALY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 94 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 95 SPAIN SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 96 SPAIN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 97 SPAIN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 98 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 99 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 100 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 101 SPAIN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 102 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 103 RUSSIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 104 RUSSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 RUSSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 106 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 107 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 108 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 109 RUSSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 110 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 111 NETHERLANDS SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 112 NETHERLANDS MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 113 NETHERLANDS MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 114 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 115 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 116 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 117 NETHERLANDS TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 118 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 119 SWITZERLAND SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 120 SWITZERLAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 121 SWITZERLAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 122 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 123 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 124 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 125 SWITZERLAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 126 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 127 TURKEY SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 TURKEY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 129 TURKEY MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 130 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 131 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 132 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 133 TURKEY TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 134 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 135 BELGIUM SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 136 BELGIUM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 137 BELGIUM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 138 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 139 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 140 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 141 BELGIUM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 142 REST OF EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 143 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 144 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 145 ASIA-PACIFIC SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 146 ASIA-PACIFIC MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 147 ASIA-PACIFIC MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 148 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 149 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 150 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 151 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 152 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 153 CHINA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 CHINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 155 CHINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 156 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 157 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 158 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 159 CHINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 160 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 161 JAPAN SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 162 JAPAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 163 JAPAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 164 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 165 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 166 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 167 JAPAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 168 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 169 INDIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 170 INDIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 171 INDIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 172 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 173 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 174 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 175 INDIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 176 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 177 SOUTH KOREA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 178 SOUTH KOREA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 179 SOUTH KOREA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 180 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 181 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 182 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 183 SOUTH KOREA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 184 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 185 AUSTRALIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 186 AUSTRALIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 187 AUSTRALIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 188 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 189 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 190 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 191 AUSTRALIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 192 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 193 SINGAPORE SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 194 SINGAPORE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 195 SINGAPORE MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 196 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 197 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 198 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 199 SINGAPORE TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 200 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 201 THAILAND SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 202 THAILAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 THAILAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 204 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 205 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 206 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 207 THAILAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 208 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 209 MALAYSIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 210 MALAYSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 211 MALAYSIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 212 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 213 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 214 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 215 MALAYSIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 216 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 217 INDONESIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 218 INDONESIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 219 INDONESIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 220 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 221 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 222 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 223 INDONESIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 224 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 225 TAIWAN SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 TAIWAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 227 TAIWAN MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 228 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 229 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 230 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 231 TAIWAN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 232 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 233 NEW ZEALAND SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 234 NEW ZEALAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 235 NEW ZEALAND MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 236 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 237 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 238 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 239 NEW ZEALAND TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 240 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 241 PHILIPPINES SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 242 PHILIPPINES MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 243 PHILIPPINES MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 244 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 245 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 246 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 247 PHILIPPINES TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 248 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 249 VIETNAM SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 250 VIETNAM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 251 VIETNAM MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 252 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 253 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 254 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 255 VIETNAM TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 256 REST OF ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 257 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 258 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 259 MIDDLE EAST AND AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 260 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 261 MIDDLE EAST AND AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 262 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 263 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 264 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 265 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 266 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 267 SOUTH AFRICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 268 SOUTH AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 269 SOUTH AFRICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 270 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 271 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 272 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 273 SOUTH AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 274 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 275 SAUDI ARABIA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 276 SAUDI ARABIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 277 SAUDI ARABIA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 278 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 279 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 280 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 281 SAUDI ARABIA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 282 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 283 U.A.E SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 284 U.A.E MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 285 U.A.E MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 286 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 287 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 288 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 289 U.A.E TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 290 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 291 EGYPT SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 292 EGYPT MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 293 EGYPT MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 294 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 295 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 296 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 297 EGYPT TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 298 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 299 ISRAEL SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 300 ISRAEL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 301 ISRAEL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 302 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 303 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 304 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 305 ISRAEL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 306 REST OF MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 307 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 308 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 309 SOUTH AMERICA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 310 SOUTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 311 SOUTH AMERICA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 312 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 313 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 314 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 315 SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 316 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 317 BRAZIL SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 318 BRAZIL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 319 BRAZIL MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 320 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 321 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 322 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 323 BRAZIL TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 324 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

TABLE 325 ARGENTINA SURGERY IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 326 ARGENTINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 327 ARGENTINA MEDICATIONS IN TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)

TABLE 328 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY PATIENT AGE, 2018-2032 (USD THOUSAND)

TABLE 329 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)

TABLE 330 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY CAUSE OF INJURY, 2018-2032 (USD THOUSAND)

TABLE 331 ARGENTINA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY END-USER, 2018-2032 (USD THOUSAND)

TABLE 332 REST OF SOUTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)

図表一覧

FIGURE 1 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: MARKET END-USER COVERAGE GRID

FIGURE 9 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: SEGMENTATION

FIGURE 11 INCREASING INCIDENCE OF TRAUMATIC BRAIN INJURY (TBI) IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 12 SURGERY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET IN THE FORECAST PERIOD OF 2025 & 2032

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 15 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: EXECUTIVE SUMMARY

FIGURE 16 STRATEGIC DECISIONS

FIGURE 17 DROC ANALYSIS

FIGURE 18 TBI-RELATED DEATHS FROM 2018 TO 2024

FIGURE 19 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, 2024

FIGURE 20 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, 2025 TO 2032 (USD THOUSAND)

FIGURE 21 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, CAGR (2025- 2032)

FIGURE 22 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE

FIGURE 23 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, 2024

FIGURE 24 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, 2025 TO 2032 (USD THOUSAND)

FIGURE 25 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, CAGR (2025- 2032)

FIGURE 26 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY PATIENT AGE, LIFELINE CURVE

FIGURE 27 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER, 2024

FIGURE 28 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER, 2025-2032 (USD THOUSAND)

FIGURE 29 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER CAGR (2025-2032)

FIGURE 30 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY GENDER, LIFELINE CURVE

FIGURE 31 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, 2024

FIGURE 32 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, 2025-2032 (USD THOUSAND)

FIGURE 33 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, CAGR (2025-2032)

FIGURE 34 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY CAUSE OF INJURY, LIFELINE CURVE

FIGURE 35 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, 2024

FIGURE 36 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, 2025-2032 (USD THOUSAND)

FIGURE 37 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, CAGR (2025-2032)

FIGURE 38 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 39 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: SNAPSHOT (2024)

FIGURE 40 MIDDLE EAST AND AFRICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)

FIGURE 41 NORTH AMERICA TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)

FIGURE 42 EUROPE TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)

FIGURE 43 ASIA-PACIFIC TRAUMATIC BRAIN INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)

詳細情報を見る

調査方法

データ収集と基準年分析は、大規模なサンプルサイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データマイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データモデルには、ベンダーポジショニンググリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニンググリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダーシェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータスタイルでいくつでも追加できます。当社のアナリストチームは、粗い生の Excel ファイルピボットテーブル (ファクトブック) でデータを提供したり、レポートで利用可能なデータセットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

What is the current market size of the Middle East and Africa Traumatic Brain Injury Treatment Market?

The traumatic brain injury treatment market size was valued at USD 202.80 million in 2024.

What is the expected growth rate of Middle East and Africa Traumatic Brain Injury Treatment Market?

The Middle East and Africa traumatic brain injury treatment market is to grow at a CAGR of 4.4% during the forecast period of 2025 to 2032.

What are the primary segments covered in the Middle East and Africa Traumatic Brain Injury Treatment Market?

The Middle East and Africa traumatic brain injury treatment market is categorized into five notable segments based on treatment, patient age, gender, cause of injury, and end-user. On the basis of treatment, the market is segmented into surgery, immediate emergency care, and medications. On the basis of patient age, the market is segmented into children, teenager, and elder. On the basis of gender, the market is segmented into male and female. On the basis of cause of injury, the market is segmented into falls, motor vehicle traffic, sports, and others. On the basis of end user, the market is segmented into hospitals, neurology clinics, independent pharmacies, and others.

Who are major players in Middle East and Africa Traumatic Brain Injury Treatment Market ?

Companies such as Pfizer Inc. (U.S.), Teva Pharmaceuticals USA, Inc. (U.S.), Fresenius SE & Co. KGaA (Fresenius Kabi AG) (Germany), Viatris Inc. (U.S.), Amneal Pharmaceuticals LLC (U.S.) are the major companies in the Middle East and Africa traumatic brain injury treatment market .

What are the recent product launches by major companyes in the Middle East and Africa Traumatic Brain Injury Treatment Market ?

In December 2024, Hikma Pharmaceuticals launched Ephedrine Sulfate Injection USP in the U.S. This medication is used to treat hypotension during anesthesia. Its introduction expands Hikma’s injectable product portfolio, providing healthcare providers with an effective solution for managing blood pressure in surgical settings and improving patient care during procedures.

Which countries data is covered in the Middle East and Africa traumatic brain injury treatment market?

The countries covered in the Middle East and Africa traumatic brain injury treatment market are Saudi Arabia, U.A.E., South Africa, Egypt, Kuwait, Israel, and rest of Middle East and Africa.

What are the key trends in the Middle East and Africa traumatic brain injury treatment market?

Key trends in the Middle East and Africa Traumatic Brain Injury Treatment Market include the increasing adoption of minimally invasive surgical techniques, rising investment in neurorehabilitation technologies, and a growing focus on personalized medicine approaches.

What are the factors driving the Middle East and Africa traumatic brain injury treatment market growth?

aThe major factors driving the growth of the Middle East and Africa traumatic brain injury treatment market are the increasing incidence of traumatic brain injuries, advancements in treatment technologies, and rising awareness about brain health and rehabilitation.

What are the major challenges in the Middle East and Africa traumatic brain injury treatment market?

Challenges in the Middle East and Africa traumatic brain injury treatment market include high treatment costs, limited access to specialized care, and variability in diagnosis and treatment protocols across different regions.

Which country is expected to dominate in the Middle East and Africa traumatic brain injury treatment market?

South Africa is expected to lead the traumatic brain injury market due to rising road accidents and improved healthcare infrastructure. Increasing government initiatives and awareness programs further support market growth.

Which country is expected to witness the highest CAGR in the Middle East and Africa traumatic brain injury treatment market?

South Africa's traumatic brain injury (TBI) assessment and management devices market is projected to grow at a compound annual growth rate (CAGR) of approximately driven by advancements in medical technology and increased awareness of TBI treatments.

Which is the dominating segment in the Middle East and Africa traumatic brain injury treatment market?

The surgery segment is expected to dominate the Middle East and Africa traumatic brain injury treatment market holding a major market share in 2025, due to increasing severe TBI cases, advancements in surgical techniques, and better post-surgery recovery outcomes, driving demand for surgical interventions.

中東・アフリカの外傷性脳損傷治療市場規模、シェア、トレンド分析レポート – 業界概要と2032年までの予測

アジャイルなサプライチェーンコンサルティングで関税の課題を回避

中東・アフリカの外傷性脳損傷治療市場規模、シェア、トレンド分析レポート

CAGR : 4.40 %

外傷性脳損傷治療市場規模

外傷性脳損傷治療市場分析

外傷性脳損傷治療市場の展望

外傷性脳損傷治療の市場シェア

外傷性脳損傷治療市場の最新動向

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

目次

表のリスト

図表一覧

調査方法

カスタマイズ可能

Frequently Asked Questions

レポート

市場洞察

サポート

ソリューション

中東・アフリカの外傷性脳損傷治療市場規模、シェア、トレンド分析レポート – 業界概要と2032年までの予測

アジャイルなサプライチェーンコンサルティングで関税の課題を回避

中東・アフリカの外傷性脳損傷治療市場規模、シェア、トレンド分析レポート

CAGR : 4.40 %

外傷性脳損傷治療市場規模

外傷性脳損傷治療市場分析

外傷性脳損傷治療市場の展望

外傷性脳損傷治療の市場シェア

外傷性脳損傷治療市場の最新動向

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

目次

表のリスト

図表一覧

調査方法

カスタマイズ可能

Frequently Asked Questions

関連ページを閲覧する